We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West is pleased to announce that the AccelTRA™ component program has been recognized with a 2018 India Packaging Award in the category of “Packaging Design in Injectables.” The award was announced during a ceremony at the 2018 InnoPack Pharma Confex in Mumbai, India on May 24, 2018.
*JP Compliance pending
**Commercial quantities available for customers in 6 weeks with provision of 90-day notification and forecast
“The AccelTRA program was designed to provide generic drug manufacturers components for injectable drug delivery that meet the challenges of today’s fast-pace market,” said Chris Ryan, VP, Global Generics, West. “West designed AccelTRA components around the ideas of quality, speed and simplicity to help address the unique needs of generic drug manufacturers to be able to quickly respond to unforecasted market demand while meeting increasing quality standards.”
The India Packaging Awards honor the leaders who drive the industry to incredible heights. The awards were the first platform in India to recognize the pharmaceutical packaging industry for their efforts, contributions and innovations. The Excellence in Packaging Design award is given to packaging initiatives that improve a product's appeal with respect to commercial, aesthetic, compliance and/or efficiency perspectives.
Launched in March 2017, the AccelTRA component program’s high-quality 4031/35 elastomer formulation enables optimized lead times, extremely low particulate levels and can withstand multiple punctures. These features help to reduce patient risk and ensure the drug and its packaging meet strict standards for quality set by regulatory agencies.
Through the AccelTRA component program, West can provide generics manufacturers with sample components for injectable drug packaging in as little as one week and commercial quantities in six weeks. Available globally, the high-quality components are offered either Ready to Sterilize or Ready to Use, have an industry-leading extractables and leachables profile and meet United States Pharmacopeia (USP) and European Pharmacopoeia (EP) compliance requirements.
“West has made a commitment to supporting the growing generics market,” noted Ryan. “By partnering with West, customers receive reliable, safe products that may help to lessen the chances that a drug product will be denied approval by a regulatory agency while at the same time providing a safe product for patients.”
For more information about the AccelTRA component program, click here.
AccelTRA™ is a trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
Today, West Pharmaceutical Services welcomed the Southeast PA Regional Veterans Consortium to its Exton, PA headquarters. The Consortium, created to bring together top employers to collectively combat the employment issues that veterans face, shares West’s dedication to this important cause.
<p>Seeking technical support? Need a little information about fill-finish manufacturing technology? How about advice from the experts on extractables and leachables? These answers, and more, are available in the new West Knowledge Center.</p><p> </p>
The global prefilled syringe market is growing rapidly, and approximately 60% of prefilled syringes use staked needles. To help ensure the integrity of the drug products contained within, the majority of staked-needle prefilled syringes use Rigid Needle Shields (RNS).
It is imperative for the pharmaceutical industry to be prepared to comply with new compendia chapters as soon as they are enacted.<span> </span>This comprises knowing of proposed changes as soon as announced, and being well prepared to accommodate them.<span> </span>Expected to be implemented by late 2018 – the functionality tests section of USP Chapter <381> (<em>Elastomeric Closure for Injections</em>) will be removed, and greatly expanded functionality tests will be incorporated in new USP Chapter <382> (projected title: <em>Elastomeric Closure Functionality in Injectable Pharmaceutical Packaging/Delivery Systems</em>).<span> </span><p> </p>
At West, Corporate Responsibility (CR) is not an afterthought. Every decision we make and action we take directly reflects our commitment to Corporate Responsibility. In the fall of 2019, West was named as a Top Company for Corporate Responsibility practices by both <em>Newsweek</em> and <em>Investor’s Business Daily.</em> We are honored to be recognized for excellence in making a positive impact in the communities where we operate and with the customers we serve.
English
Chinese
